Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Kaye Randall Create: Alert

All | News | Filings
Date FiledTypeDescription
01/11/2010 4/A Kaye Randall (Sr. VP, Chief Medical Officer) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 28,079 shares @ $1.97, valued at $55.3k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy